Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dr Soliman Abdul Kader Fakeeh Hospital CoSAU:4017 +0.99%14 Return-on-Tangible-Equity is 5.81% as of Mar. 2026, which is 71% below its 10-year median of 19.99. GuruFocus rates SAU:4017 with a GF Score™ of 14/100. The stock has 4 warning signs investors should review. Among 576 Healthcare Providers & Services companies, Dr Soliman Abdul Kader Fakeeh Hospital Co ranks worse than 50.52% on this metric.
SAU:4017'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 10 Med: 19.99 Max: 58.74
Current: 10
During the past 3 years, Dr Soliman Abdul Kader Fakeeh Hospital Co's highest Return-on-Tangible-Equity was 58.74%. The lowest was 10.00%. And the median was 19.99%.
SAU:4017's Return-on-Tangible-Equity is ranked worse than 50.52% of 576
companies
in the Healthcare Providers & Services industry
Industry Median: 10.17
vs SAU:4017: 10.00
Dr Soliman Abdul Kader Fakeeh Hospital Co (SAU:4017) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Dr Soliman Abdul Kader Fakeeh Hospital Co Return-on-Tangible-Equity Related Terms
Dr Soliman Abdul Kader Fakeeh Hospital Co Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Soliman Abdul Kader Fakeeh Hospital Co Return-on-Tangible-Equity Chart
Dr Soliman Abdul Kader Fakeeh Hospital Co Annual Data
Trend
Dec23
Dec24
Dec25
Return-on-Tangible-Equity
58.74
19.99
11.55
Dr Soliman Abdul Kader Fakeeh Hospital Co Quarterly Data
SAU:4017 vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Dr Soliman Abdul Kader Fakeeh Hospital Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Soliman Abdul Kader Fakeeh Hospital Co Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dr Soliman Abdul Kader Fakeeh Hospital Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Dr Soliman Abdul Kader Fakeeh Hospital Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 5.81% mean?
Dr Soliman Abdul Kader Fakeeh Hospital Co (SAU:4017) has a Return-on-Tangible-Equity of 5.81% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Dr Soliman Abdul Kader Fakeeh Hospital Co and its competitors. This is 71% below median its historical median of 19.99. Over the past decade, Dr Soliman Abdul Kader Fakeeh Hospital Co's Return-on-Tangible-Equity has ranged from 10.00 to 58.74. According to the industry distribution chart, Dr Soliman Abdul Kader Fakeeh Hospital Co ranks #291 out of 576 companies in the Healthcare Providers & Services industry, placing it in the top 50.5%.
Is Dr Soliman Abdul Kader Fakeeh Hospital Co's Return-on-Tangible-Equity too high?
Dr Soliman Abdul Kader Fakeeh Hospital Co's current Return-on-Tangible-Equity of 5.81% is 71% below median its 10-year median of 19.99. Over the past 10 years, this metric has ranged from a low of 10.00 to a high of 58.74. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.17. Dr Soliman Abdul Kader Fakeeh Hospital Co's value of 5.81% is 42.9% below this industry median. Based on the distribution chart, Dr Soliman Abdul Kader Fakeeh Hospital Co ranks #291 out of 576 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Dr Soliman Abdul Kader Fakeeh Hospital Co has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Dr Soliman Abdul Kader Fakeeh Hospital Co's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dr Soliman Abdul Kader Fakeeh Hospital Co ranks #291 out of 576 companies for Return-on-Tangible-Equity. This places Dr Soliman Abdul Kader Fakeeh Hospital Co in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.17. Dr Soliman Abdul Kader Fakeeh Hospital Co's value of 5.81% is 42.9% below this benchmark. Historically, Dr Soliman Abdul Kader Fakeeh Hospital Co's own Return-on-Tangible-Equity has ranged from 10.00 to 58.74 over the past decade. While the company's 10-year median is 19.99 vs. the industry median of 10.17, Dr Soliman Abdul Kader Fakeeh Hospital Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.17, based on 576 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Soliman Abdul Kader Fakeeh Hospital Co's current Return-on-Tangible-Equity of 5.81% is 42.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Dr Soliman Abdul Kader Fakeeh Hospital Co and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Soliman Abdul Kader Fakeeh Hospital Co's current Return-on-Tangible-Equity is 5.81%, which is 71% below median its own 10-year median of 19.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Soliman Abdul Kader Fakeeh Hospital Co stock overvalued right now?
Dr Soliman Abdul Kader Fakeeh Hospital Co (SAU:4017) has a current Return-on-Tangible-Equity of 5.81%. The current Return-on-Tangible-Equity is 5.81%, which is 71% below median its 10-year median of 19.99 and 42.9% below the Healthcare Providers & Services industry median of 10.17. Dr Soliman Abdul Kader Fakeeh Hospital Co's overall GF Score™ is 14/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Dr Soliman Abdul Kader Fakeeh Hospital Co (SAU:4017), the current Return-on-Tangible-Equity is 5.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Dr Soliman Abdul Kader Fakeeh Hospital Co Business Description
Dr Soliman Abdul Kader Fakeeh Hospital Co is a company whose principal activities include managing, establishing, and operating hospitals, clinics, medical, educational, and training centers. In addition to the above, the company is also managing and operating medical services, analysis and radiology laboratory, and managing and establishing pharmacies, wholesale and retail of medical equipment, maintenance of IT equipment, and software-related services. The group has three reportable segments, including medical services, which generates maximum revenue, education, trading, retail, and others. Geographically, it principally operates in the Kingdom of Saudi Arabia.
14GF Score
Get the complete analysis for SAU:4017
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4017 has been successfully added to your 
